Canntab Therapeutics Limited announced that the Company has received approval from the Province of Saskatchewan to sell the entire portfolio of Canntab solid oral dose products to their wholesale and provincial stores effective immediately.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
Apr. 15 | Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding | CI |
2023 | Canntab Therapeutics Limited Provide an Update on Product Delivery | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 142K | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
+0.09% | 1.65B | |
-7.89% | 1.68B | |
-12.97% | 1.53B | |
+33.40% | 1.38B |
- Stock Market
- Equities
- PILL Stock
- News Canntab Therapeutics Limited
- Canntab Therapeutics Limited Receives Approval from the Province of Saskatchewan to Begin Sales